2026-04981
RegulationMandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels
Introduced: March 13, 2026
Progress
Summary
HHS herein publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in federal workplace drug testing programs. The Department has made no revisions to the current drug testing panels for both urine and oral fluid and current required nomenclature for laboratory and Medical Review Officer Reports, effective July 7, 2025.
How This Affects You
Related Bills
HR 8052
To amend title 38, United States Code, to require that a sterile processing technician of the Veterans Health Administration holds an appropriate professional certification, and for other purposes
S 921
Tyler’s Law
HR 8043
To amend title 38, United States Code, to improve the efficiency of the recovery and collection of revenue for the Department of Veterans Affairs Medical Care Collections Fund, and for other purposes
HR 8067
To direct the Secretary of Health and Human Services to carry out a program under which the Secretary will collect data with respect to sickle cell disease in the United States, and for other purposes
S 864
HELP Copays Act
Get personalized insights on this bill
CivicRadar tells you exactly how government actions affect your life based on your location, interests, and profession.